Jöhrer K - Search Results

1

Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors.

Ganghammer S, Gutjahr J, Hutterer E, Krenn PW, Pucher S, Zelle-Rieser C, Jöhrer K, Wijtmans M, Leurs R, Smit MJ, Gattei V, Greil R, Hartmann TN. Ganghammer S, et al. Among authors: johrer k. Haematologica. 2016 Mar;101(3):e99-102. doi: 10.3324/haematol.2015.133470. Epub 2015 Nov 20. Haematologica. 2016. PMID: 26589908 Free PMC article. No abstract available.

2

Histone deacetylase inhibitors potently repress CXCR4 chemokine receptor expression and function in acute lymphoblastic leukaemia.

Crazzolara R, Jöhrer K, Johnstone RW, Greil R, Kofler R, Meister B, Bernhard D. Crazzolara R, et al. Among authors: johrer k. Br J Haematol. 2002 Dec;119(4):965-9. doi: 10.1046/j.1365-2141.2002.03955.x. Br J Haematol. 2002. PMID: 12472574 Free article.

3

Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools.

Greil R, Anether G, Johrer K, Tinhofer I. Greil R, et al. Among authors: johrer k. J Leukoc Biol. 2003 Sep;74(3):311-30. doi: 10.1189/jlb.0802416. J Leukoc Biol. 2003. PMID: 12949235 Review.

4

Tuning the rheostat of the myelopoietic system via Fas and TRAIL.

Greil R, Anether G, Johrer K, Tinhofer I. Greil R, et al. Among authors: johrer k. Crit Rev Immunol. 2003;23(4):301-22. doi: 10.1615/critrevimmunol.v23.i4.30. Crit Rev Immunol. 2003. PMID: 14700272 Review.

5

Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1.

Jöhrer K, Janke K, Krugmann J, Fiegl M, Greil R. Jöhrer K, et al. Clin Cancer Res. 2004 Mar 15;10(6):1901-10. doi: 10.1158/1078-0432.ccr-1053-03. Clin Cancer Res. 2004. PMID: 15041705

6

Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma.

Jöhrer K, Zelle-Rieser C, Perathoner A, Moser P, Hager M, Ramoner R, Gander H, Höltl L, Bartsch G, Greil R, Thurnher M. Jöhrer K, et al. Clin Cancer Res. 2005 Apr 1;11(7):2459-65. doi: 10.1158/1078-0432.CCR-04-0405. Clin Cancer Res. 2005. PMID: 15814620

7

Tumour-immune cell interactions modulated by chemokines.

Jöhrer K, Pleyer L, Olivier A, Maizner E, Zelle-Rieser C, Greil R. Jöhrer K, et al. Expert Opin Biol Ther. 2008 Mar;8(3):269-90. doi: 10.1517/14712598.8.3.269. Expert Opin Biol Ther. 2008. PMID: 18294099 Review.

8

Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.

Hofbauer SW, Piñón JD, Brachtl G, Haginger L, Wang W, Jöhrer K, Tinhofer I, Hartmann TN, Greil R. Hofbauer SW, et al. Among authors: johrer k. Cancer Res. 2010 Sep 15;70(18):7336-44. doi: 10.1158/0008-5472.CAN-09-4411. Epub 2010 Sep 7. Cancer Res. 2010. PMID: 20823161

9

Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic target.

Jöhrer K, Obkircher M, Neureiter D, Parteli J, Zelle-Rieser C, Maizner E, Kern J, Hermann M, Hamacher F, Merkel O, Wacht N, Zidorn C, Scheideler M, Greil R. Jöhrer K, et al. J Mol Med (Berl). 2012 Jun;90(6):681-93. doi: 10.1007/s00109-011-0848-x. Epub 2011 Dec 29. J Mol Med (Berl). 2012. PMID: 22205266

10

Chemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma - targets for therapeutic intervention?

Jöhrer K, Hofbauer SW, Zelle-Rieser C, Greil R, Hartmann TN. Jöhrer K, et al. Expert Opin Biol Ther. 2012 Apr;12(4):425-41. doi: 10.1517/14712598.2012.664128. Epub 2012 Feb 15. Expert Opin Biol Ther. 2012. PMID: 22332909 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters